ATOS - CIK 0001488039
ATOSSA THERAPEUTICS, INC. trades as ATOS. This page tracks ATOSSA THERAPEUTICS, INC. through 634 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 4 fiscal years ATOSSA THERAPEUTICS, INC.'s revenue grew from $1.50K to $1.76K, a compound annual growth rate of 4.0%.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Major company event | 8-K | 2026-05-08 |
| Quarterly report | 10-Q | 2026-05-08 |
The largest companies sharing ATOSSA THERAPEUTICS, INC.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year ATOSSA THERAPEUTICS, INC. reported a net loss of $34.77M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.